Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34- Clinical Trial Required) | RFA MH 18 706

Frequently Asked Questions (FAQs)

What is the Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34 - Clinical Trial Required) opportunity?

This is a National Institutes of Health (NIH) funding opportunity from the National Institute of Mental Health (NIMH) that supports early-stage, real-world pilot testing of mental health interventions and service approaches. It is intended to help investigators move from a successful efficacy study (controlled conditions) to a later, larger effectiveness, pragmatic, or services trial (routine/community conditions).

What is the main purpose of this R34 pilot mechanism?

The R34 is designed as a bridge between efficacy research and a full-scale effectiveness or services trial. The goal is to fund pilot work that reduces uncertainty by generating practical evidence and preliminary data needed to justify, shape, and successfully launch a larger and more expensive definitive trial.

What kinds of studies does this FOA prioritize?

The FOA prioritizes pilot clinical trials that evaluate whether an intervention that worked under controlled conditions can still work when delivered to broader, more diverse populations or implemented in typical practice/community settings where staffing, resources, and patient needs differ from research environments.

What does "real-world testing" mean in the context of this opportunity?

Real-world testing refers to evaluating interventions in typical community or practice settings (for example, clinics, schools, or service systems) under routine constraints such as limited session time, varied provider training, and common patient comorbidities, rather than idealized research conditions.

What are the two broad categories of projects supported by this FOA?

The FOA supports (1) effectiveness research on preventive and therapeutic interventions that have already demonstrated efficacy, and (2) development and preliminary testing of innovative services interventions aimed at improving how mental health services are delivered, accessed, coordinated, or sustained.

What qualifies as an effectiveness research project under this opportunity?

Effectiveness research projects focus on preventive or therapeutic interventions that already have evidence of efficacy and aim to extend their use to wider target populations and/or implement them in community practice settings. This can include adapting delivery to new contexts and testing performance under routine conditions.

What qualifies as a services intervention project under this opportunity?

Services intervention projects focus on improving mental health service delivery and systems, including strategies to improve service quality, reach, equity, efficiency, engagement, coordination, access, or sustainability. These projects involve developing and conducting preliminary testing of innovative approaches to service delivery.

Is a clinical trial required for this funding opportunity?

Yes. The FOA is explicitly labeled "Clinical Trial Required," meaning the proposed study must meet NIH's definition of a clinical trial and include prospective assignment to an intervention to evaluate effects on health-related outcomes.

What does NIH mean by a "clinical trial" for this FOA?

In this context, a clinical trial involves prospectively assigning participants to an intervention (or conditions) in order to evaluate the intervention's effects on health-related outcomes. The FOA is not intended for purely observational, descriptive, retrospective, or non-intervention studies.

Are small or pilot randomized designs appropriate for this FOA?

Yes. The FOA emphasizes pilot-scale clinical trials, and competitive applications commonly use pilot randomized designs, small pragmatic trials, or carefully structured single-site or limited multi-site pilots to demonstrate that key procedures are workable prior to scaling up.

What types of pilot evidence does the FOA emphasize generating?

The FOA emphasizes evidence needed before launching a larger trial, especially around feasibility, tolerability, acceptability, and safety, along with preliminary data that can justify and guide the design of a subsequent full-scale effectiveness or services study.

What does feasibility mean in this FOA?

Feasibility refers to whether the study and intervention can actually be carried out as planned in the intended setting. This includes whether recruitment, retention, adherence, measurement, fidelity, and implementation procedures are workable under real-world conditions.

What does tolerability mean in this FOA?

Tolerability refers to whether participants can reasonably endure or continue the intervention without undue burden. In a pilot context, this often relates to participant burden, willingness to continue, and whether the delivery approach is manageable for those receiving it.

What does acceptability mean in this FOA?

Acceptability refers to whether participants, providers, and organizations are willing to use the intervention or service approach. It reflects how the approach is perceived and whether it is practical and desirable in routine settings.

What does safety mean in this FOA?

Safety refers to monitoring for adverse events or negative outcomes related to the intervention or service approach. The FOA highlights safety as a core pilot outcome to support responsible scaling to a larger study.

What outcomes are emphasized beyond symptom change?

The FOA emphasizes outcomes beyond symptoms, including mental health and functional outcomes, modification of risk factors, and measurable improvements in service delivery (particularly for services intervention projects).

What is the intended "next step" after an R34 pilot funded under this FOA?

The intended next step is a larger and more definitive study, such as a comparative effectiveness study, a pragmatic (practical) trial, or a large-scale services study. The R34 is meant to refine procedures and strengthen the rationale for that later trial.

What types of settings might be relevant for projects under this FOA?

The FOA signals interest in research embedded in settings where people actually receive services, including community clinics, schools, social service systems, and diverse local or tribal communities, among other routine practice environments.

Who is eligible to apply for this opportunity?

Eligibility is broad and includes many organization types and governments, such as state/county/city/township governments, special district governments, independent school districts, public and state-controlled institutions of higher education, private institutions of higher education, tribal governments, tribal organizations, public housing authorities, nonprofits (with or without 501(c)(3) status, other than institutions of higher education), for-profit organizations (other than small businesses), and small businesses.

Are institutions serving specific populations explicitly included as eligible applicants?

Yes. The FOA explicitly notes additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving Institutions, HBCUs, and TCCUs.

Are faith-based or community-based organizations eligible?

Yes. The FOA explicitly includes faith-based or community-based organizations among eligible applicants.

Are U.S. territories or possessions included in eligibility?

Yes. The FOA explicitly includes U.S. territories or possessions among eligible applicants.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The FOA explicitly indicates that non-domestic (non-U.S.) entities or foreign organizations are eligible applicants.

Can federal agencies apply?

Yes. The FOA explicitly includes eligible federal agencies among potential applicants.

What is the opportunity number for this FOA?

The funding opportunity is identified as RFA-MH-18-706.

Which NIH institute is associated with this funding opportunity?

The opportunity is associated with the National Institute of Mental Health (NIMH) within NIH.

How is this grant categorized in the listing?

It is categorized as a discretionary grant under the health funding activity category.

What is the CFDA number for this opportunity?

The CFDA number listed for this opportunity is 93.242.

What are the key dates shown in the provided listing?

The posting indicates it was created on 2017-11-14, with an original closing date of 2021-02-18.

Does the provided information include an award ceiling or expected number of awards?

No. The provided text does not specify an award ceiling or the expected number of awards.

What is the overall "spirit" of the mechanism even though a clinical trial is required?

Even with the clinical trial requirement, the mechanism is intended to remain pilot-scale. It supports a true test of an intervention in a smaller or limited context to determine whether scaling up to a larger trial is justified and how it should be designed.

What types of challenges in routine settings is this FOA trying to address through pilot testing?

The FOA highlights that routine settings often differ from research environments in resources, staffing, provider training, time constraints, and patient complexity (including typical comorbidities). Pilot testing under this mechanism helps determine whether the intervention and study procedures can succeed under those realistic conditions.